Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 635
Recruiting: 365
Ph III recruiting: 20
Growth YoY: −15.2%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (367)

clinicaltrialsPublishedShowing 401–450 of 784 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06753136	Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype	recruiting	N/A	24	Istituto Oncologico Veneto IRCCSOTHER	1	Apr 13, 2026	clinicaltrials
NCT06935409	Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure	active not recruiting	Phase 3	117	Hansoh BioMedical R&D CompanyINDUSTRY	1	Apr 9, 2026